Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
17%
Cancer Pain
5%
Case-Control Study
16%
Chronic Myeloid Leukemia
50%
Cohort Study
68%
Cross-Sectional Study
17%
Defined Daily Dose
19%
Disease
22%
Drug Utilization
18%
Duragesic
5%
Gabapentinoid
19%
Imatinib
41%
Infection
16%
Long Term Survival
11%
Malignant Neoplasm
10%
Morphine
16%
Mortality Rate
7%
Opiate
100%
Prevalence
20%
Psoriasis
33%
Psoriatic Arthritis
16%
Psychotropic Agent
18%
Randomized Controlled Trial
16%
Tramadol
37%
Medicine and Dentistry
Breast Cancer
16%
Charlson Comorbidity Index
6%
Chronic Myelogenous Leukemia
33%
Cohort Analysis
35%
Drug Therapy
9%
Estrogen Receptor
16%
Frailty
16%
Gene Linkage
10%
Hazard Ratio
19%
Health Care Cost
7%
High Risk Population
6%
Hormone Therapy
16%
Imatinib
25%
Infection
16%
Long Term Survival
11%
Meta-Analysis
16%
Opiate
16%
Overall Survival
6%
Psoriasis
33%
Quality of Life Measure
16%
Randomized Controlled Trial
16%
Scoring System
8%
Tramadol
16%
Treatment Response
6%
Nursing and Health Professions
Cancer Pain
5%
Chronic Myeloid Leukemia
16%
Clinical Outcome
16%
Cohort Analysis
27%
Confidence Interval
36%
Cross-Sectional Study
16%
Drug Therapy
6%
Duragesic
5%
Hazard Ratio
13%
Imatinib
33%
Infection
16%
Malignant Neoplasm
7%
Meta Analysis
16%
Morphine
7%
National Health Insurance
18%
Odds Ratio
7%
Opiate
33%
Primary Medical Care
16%
Psoriasis
16%
Tramadol
33%
